Proceeding contribution from Ian Gibson (Labour) in the House of Commons on Thursday, 8 December 2005. It occurred during Estimates day on Department of Health.
Department of Health
Did the Committee’s study of research reach any conclusion on the merger mania in the pharmaceutical industry? When Glaxo and SmithKline merged, Sir Richard Sykes and Jan Leschly said that research would benefit from the merger because they would be working together. Is there any evidence that mergers lead to better research?
Secondary information
- Type
- Proceeding contribution
- Reference
- 440 c1049
- Session
- 2005-06
- Chamber / Committee
- House of Commons chamber
- Subjects
- Advertising Licensing Expenditure Drugs Government departments Industry Prescription drugs Department of Health Medicines and Healthcare products Regulatory Agency Research Regulation Safety National Institute for Health and Care Excellence Registration Clinical trials
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2025-11-24 15:50:33 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_285138
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_285138
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_285138